Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

[1]  R. Alroughani.  Paediatric multiple sclerosis , 2019, Journal of the Neurological Sciences.

[2]  À. Rovira,et al.  The value of oligoclonal bands in the multiple sclerosis diagnostic criteria , 2018, Brain : a journal of neurology.

[3]  À. Rovira,et al.  Lesion topographies in multiple sclerosis diagnosis , 2017, Neurology.

[4]  O. Ciccarelli,et al.  Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study , 2017, The Lancet Neurology.

[5]  L. Leocani,et al.  Multiple biomarkers improve the prediction of multiple sclerosis in clinically isolated syndromes , 2017, Acta neurologica Scandinavica.

[6]  A. Solomon,et al.  The tension between early diagnosis and misdiagnosis of multiple sclerosis , 2017, Nature Reviews Neurology.

[7]  M. Filippi,et al.  Diagnosis of multiple sclerosis: a multicentre study to compare revised McDonald-2010 and Filippi-2010 criteria , 2017, Journal of Neurology, Neurosurgery, and Psychiatry.

[8]  O. Ciccarelli,et al.  Diagnostic algorithm for relapsing acquired demyelinating syndromes in children , 2017, Neurology.

[9]  O. Ciccarelli,et al.  Periventricular lesions and MS diagnostic criteria in young adults with typical clinically isolated syndromes , 2017, Multiple sclerosis.

[10]  David H. Miller,et al.  Diagnosis of multiple sclerosis: progress and challenges , 2017, The Lancet.

[11]  Roland G. Henry,et al.  The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative , 2016, Nature Reviews Neurology.

[12]  B. Weinshenker,et al.  Progressive solitary sclerosis , 2016, Neurology.

[13]  F. Paul,et al.  Importance of cerebrospinal fluid analysis in the era of McDonald 2010 criteria: a German–Austrian retrospective multicenter study in patients with a clinically isolated syndrome , 2016, Journal of Neurology.

[14]  Gregory F. Wu,et al.  The contemporary spectrum of multiple sclerosis misdiagnosis , 2016, Neurology.

[15]  À. Rovira,et al.  Contribution of the symptomatic lesion in establishing MS diagnosis and prognosis , 2016, Neurology.

[16]  F. Paul,et al.  MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin , 2016, Journal of Neuroinflammation.

[17]  C. Lucchinetti,et al.  Acute disseminated encephalomyelitis , 2016, Neurology.

[18]  O. Ciccarelli,et al.  Should the symptomatic region be included in dissemination in space in MRI criteria for MS? , 2016, Neurology.

[19]  B. Ertl-Wagner,et al.  Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis , 2016, Neurology: Neuroimmunology & Neuroinflammation.

[20]  P. Aspelin,et al.  Incidence of Radiologically Isolated Syndrome: A Population-Based Study , 2016, American Journal of Neuroradiology.

[21]  P. Clavelou,et al.  Evaluation of quality of life and fatigue in radiologically isolated syndrome. , 2016, Revue neurologique.

[22]  M. Tintoré,et al.  CSF examination still has value in the diagnosis of MS – Commentary , 2016, Multiple sclerosis.

[23]  D. Reich,et al.  Revised Recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple Sclerosis , 2016, American Journal of Neuroradiology.

[24]  C. Tan.  International consensus diagnostic criteria for neuromyelitis optica spectrum disorders , 2016, Neurology.

[25]  O. Ciccarelli,et al.  MRI CRITERIA FOR THE DIAGNOSIS OF MULTIPLE SCLEROSIS: MAGNIMS CONSENSUS GUIDELINES , 2016, The Lancet Neurology.

[26]  K. Fujihara,et al.  Myelin injury without astrocytopathy in neuroinflammatory disorders with MOG antibodies , 2016, Journal of Neurology, Neurosurgery & Psychiatry.

[27]  M. Sormani,et al.  Primary Progressive Multiple Sclerosis Evolving From Radiologically Isolated Syndrome , 2015, Annals of neurology.

[28]  F. Barkhof,et al.  Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—establishing disease prognosis and monitoring patients , 2015, Nature Reviews Neurology.

[29]  F. Barkhof,et al.  Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—clinical implementation in the diagnostic process , 2015, Nature Reviews Neurology.

[30]  À. Rovira,et al.  Defining high, medium and low impact prognostic factors for developing multiple sclerosis. , 2015, Brain : a journal of neurology.

[31]  Darin T. Okuda,et al.  Early CNS neurodegeneration in radiologically isolated syndrome , 2015, Neurology: Neuroimmunology & Neuroinflammation.

[32]  K. Fujihara,et al.  MOG cell-based assay detects non-MS patients with inflammatory neurologic disease , 2015, Neurology: Neuroimmunology & Neuroinflammation.

[33]  Jacqueline A Palace,et al.  Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children , 2015, Neurology: Neuroimmunology & Neuroinflammation.

[34]  F. Jacques.  Defining the clinical course of multiple sclerosis: The 2013 revisions , 2015, Neurology.

[35]  S. Rauch,et al.  Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study , 2015, Multiple sclerosis.

[36]  Y. Kong,et al.  Multiple sclerosis in Japan appears to be a milder disease compared to the UK , 2015, Journal of Neurology.

[37]  C. Juhász,et al.  Use of the 2010 McDonald criteria can facilitate early diagnosis of pediatric multiple sclerosis in a predominantly black cohort. , 2014, Pediatric neurology.

[38]  David H. Miller,et al.  Vision and vision-related outcome measures in multiple sclerosis , 2014, Brain : a journal of neurology.

[39]  M. Papadopoulos,et al.  Treatment of neuromyelitis optica: state-of-the-art and emerging therapies , 2014, Nature Reviews Neurology.

[40]  A. Boyko,et al.  Revised McDonald criteria for multiple sclerosis diagnostics in Central Russia: Sensitivity and specificity , 2014, Multiple sclerosis.

[41]  T. Kezuka,et al.  Distinction between MOG antibody–positive and AQP4 antibody–positive NMO spectrum disorders , 2014, Neurology.

[42]  Jeffrey A. Cohen,et al.  Defining the clinical course of multiple sclerosis: the 2013 revisions. , 2014, Neurology.

[43]  Mike P. Wattjes,et al.  Morphological features of MS lesions on FLAIR* at 7 T and their relation to patient characteristics , 2014, Journal of Neurology.

[44]  M. Eliasziw,et al.  Application and a proposed modification of the 2010 McDonald criteria for the diagnosis of multiple sclerosis in a Canadian cohort of patients with clinically isolated syndromes , 2014, Multiple sclerosis.

[45]  Suk-Won Ahn,et al.  Evaluation of McDonald MRI criteria for dissemination in space in Korean patients with clinically isolated syndromes , 2014, Multiple sclerosis.

[46]  À. Rovira,et al.  Radiologically Isolated Syndrome: 5-Year Risk for an Initial Clinical Event , 2014, PloS one.

[47]  F. Barkhof,et al.  Diagnostic value of brain chronic black holes on T1-weighted MR images in clinically isolated syndromes , 2014, Multiple sclerosis.

[48]  M. Ramanathan,et al.  Prevalence of Radiologically Isolated Syndrome and White Matter Signal Abnormalities in Healthy Relatives of Patients with Multiple Sclerosis , 2014, American Journal of Neuroradiology.

[49]  R. Hintzen,et al.  Application of the 2010 revised criteria for the diagnosis of multiple sclerosis to patients with clinically isolated syndromes , 2013, European journal of neurology.

[50]  Massimo Filippi,et al.  Seven‐tesla phase imaging of acute multiple sclerosis lesions: A new window into the inflammatory process , 2013, Annals of neurology.

[51]  S. Chatzipanagiotou,et al.  Prevalence of cerebrospinal fluid oligoclonal IgG bands in Greek patients with clinically isolated syndrome and multiple sclerosis , 2013, Clinical Neurology and Neurosurgery.

[52]  E. Kontopantelis,et al.  Predicting multiple sclerosis following isolated optic neuritis in children , 2013, European journal of neurology.

[53]  A. Rocha,et al.  Central nervous system infectious diseases mimicking multiple sclerosis: recognizing distinguishable features using MRI. , 2013, Arquivos de neuro-psiquiatria.

[54]  W. Brück,et al.  Pediatric onset multiple sclerosis: McDonald criteria 2010 and the contribution of spinal cord MRI , 2013, Multiple sclerosis.

[55]  Chung-Ping Lo,et al.  Comparison of the 2010 and 2005 versions of the McDonald MRI criteria for dissemination-in-time in Taiwanese patients with classic multiple sclerosis , 2013, Journal of the Neurological Sciences.

[56]  E. Meinl,et al.  The utility of cerebrospinal fluid analysis in patients with multiple sclerosis , 2013, Nature Reviews Neurology.

[57]  B. Banwell,et al.  2010 McDonald criteria in a pediatric cohort: is positivity at onset associated with a more aggressive multiple sclerosis course? , 2013, Multiple sclerosis.

[58]  E. Tantsis,et al.  Risk of multiple sclerosis after a first demyelinating syndrome in an Australian Paediatric cohort: clinical, radiological features and application of the McDonald 2010 MRI criteria , 2013, Multiple sclerosis.

[59]  A. Ghezzi,et al.  International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions , 2013, Multiple sclerosis.

[60]  T. Alsaadi,et al.  Consensus guidelines for the diagnosis and treatment of multiple sclerosis , 2013, Current medical research and opinion.

[61]  G. Giovannoni,et al.  Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[62]  E. Cristiano,et al.  Application of the McDonald 2010 criteria for the diagnosis of multiple sclerosis in an Argentinean cohort of patients with clinically isolated syndromes , 2013, Multiple sclerosis.

[63]  A. Lugaresi,et al.  Risk of multiple sclerosis following clinically isolated syndrome: a 4-year prospective study , 2013, Journal of Neurology.

[64]  A. Traboulsee,et al.  Treatment of Neuromyelitis Optica: Review and Recommendations. , 2012, Multiple sclerosis and related disorders.

[65]  D. Arnold,et al.  2010 McDonald criteria for diagnosing pediatric multiple sclerosis , 2012, Annals of neurology.

[66]  P. Huppke,et al.  Anti-myelin oligodendrocyte glycoprotein antibodies in pediatric patients with optic neuritis. , 2012, Archives of neurology.

[67]  E. Wassmer,et al.  Paediatric multiple sclerosis: examining utility of the McDonald 2010 criteria , 2012, Multiple sclerosis.

[68]  D. Prayer,et al.  Evaluation of the 2010 McDonald multiple sclerosis criteria in children with a clinically isolated syndrome , 2012, Multiple sclerosis.

[69]  D. Pelletier,et al.  Impact of pregnancy on conversion to clinically isolated syndrome in a radiologically isolated syndrome cohort , 2012, Multiple sclerosis.

[70]  A. Ramos-González,et al.  Application of the 2010 McDonald criteria for the diagnosis of multiple sclerosis in a Spanish cohort of patients with clinically isolated syndromes , 2012, Multiple sclerosis.

[71]  Jeffrey A. Cohen,et al.  Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.

[72]  D. Goodin,et al.  Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome , 2011, Neurology.

[73]  M. Filippi,et al.  Intracortical lesions , 2010, Neurology.

[74]  R. Fox,et al.  Diagnosing multiple sclerosis at a later age: more than just progressive myelopathy , 2010, Multiple sclerosis.

[75]  F. Blanc,et al.  Cognitive function in radiologically isolated syndrome , 2010, Multiple sclerosis.

[76]  J. Bennett,et al.  Potential of a unique antibody gene signature to predict conversion to clinically definite multiple sclerosis , 2009, Journal of Neuroimmunology.

[77]  Yoshito Tsushima,et al.  Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis , 2009, BMJ : British Medical Journal.

[78]  J. Simon,et al.  The radiologically isolated syndrome , 2009, Neurology.

[79]  Jeffrey A. Cohen,et al.  Differential diagnosis of suspected multiple sclerosis: a consensus approach , 2008, Multiple sclerosis.

[80]  M. Rovaris,et al.  Will Rogers phenomenon in multiple sclerosis , 2008, Annals of neurology.

[81]  Frederik Barkhof,et al.  Grey matter pathology in multiple sclerosis , 2008, The Lancet Neurology.

[82]  A. Rovira,et al.  Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis? , 2008, Neurology.

[83]  B. Kis,et al.  Clinical characteristics of patients with late-onset multiple sclerosis , 2008, Journal of Neurology.

[84]  David H. Miller,et al.  MRI and the diagnosis of multiple sclerosis: expanding the concept of “no better explanation” , 2006, The Lancet Neurology.

[85]  S. Reingold,et al.  Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria” , 2005, Annals of neurology.

[86]  A. Verkman,et al.  The Journal of Experimental Medicine CORRESPONDENCE , 2005 .

[87]  Gavin Giovannoni,et al.  Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement. , 2005, Archives of neurology.

[88]  A. Thompson,et al.  Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis , 2005, The Lancet Neurology.

[89]  Ichiro Nakashima,et al.  A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis , 2004, The Lancet.

[90]  J. Corboy,et al.  338 INITIAL EVALUATIONS FOR MULTIPLE SCLEROSIS IN A UNIVERSITY MULTIPLE SCLEROSIS CENTER: OUTCOMES AND ROLE OF MAGNETIC RESONANCE IMAGING IN REFERRAL. , 2004, Journal of Investigative Medicine.

[91]  À. Rovira,et al.  Isolated demyelinating syndromes: comparison of CSF oligoclonal bands and different MR imaging criteria to predict conversion to CDMS , 2001, Multiple sclerosis.

[92]  B. Trapp,et al.  Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions , 2001, Annals of neurology.

[93]  A. Compston,et al.  Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.

[94]  C. Poser,et al.  Diagnostic criteria for multiple sclerosis , 2001, Clinical Neurology and Neurosurgery.

[95]  G. Comi,et al.  Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. , 1997, Brain : a journal of neurology.

[96]  C. Poser.  Misdiagnosis of multiple sclerosis and β-interferon , 1997, The Lancet.

[97]  G. Bernardi,et al.  Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[98]  R. Schiffer,et al.  Multiple sclerosis. The problem of incorrect diagnosis. , 1986, Archives of neurology.

[99]  T. J. Murray,et al.  Characteristics of patients found not to have multiple sclerosis. , 1984, Canadian Medical Association journal.

[100]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.

[101]  G. Dean.  The multiple sclerosis problem. , 1970, Scientific American.

[102]  F. Mcdowell,et al.  PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS , 1965, Annals of the New York Academy of Sciences.

[103]  R. Alroughani,et al.  Predictors of Conversion toMultiple Sclerosis in Patients with Clinical Isolated Syndrome Using the 2010 RevisedMcDonald Criteria , 2014 .

[104]  F. Barkhof,et al.  MRI mimics of multiple sclerosis. , 2014, Handbook of clinical neurology.

[105]  A. Osborn.  Incidental MRI anomalies suggestive of multiple sclerosis: The radiologically isolated syndrome , 2010 .

[106]  C. Poser.  Misdiagnosis of multiple sclerosis and beta-interferon. , 1997, Lancet.